Co-Diagnostics (CODX) IV at 279 on wide price movement
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/10/2026
- Nasdaq ends sharply higher; chip surge offsets Iran worries
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Applied Materials surges as CEO signals multi-year chip boom
- Oil prices settle 2% lower as economic worries outweigh supply risks
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- Key things to know ahead of SK Hynix’s blockbuster US listing
- Meta falls as massive AI infrastructure spending plans overshadow chip progress
- S&P Downgrades Oracle To 'bbb-/A-3'; Outlook Stable
- Software stocks slide as Starbucks builds AI tools to replace vendor software
- Citi names top picks in software ahead of Q2 earnings
Co-Diagnostics (CODX) Reports In-Line Q1 EPS, Revenues Beat
May 14, 2020 4:35 PM EDTCo-Diagnostics (NASDAQ: CODX) reported Q1 EPS of ($0.05), in-line with the analyst estimate of ($0.05). Revenue for the quarter came in at $1.55 million versus the consensus estimate of $620 thousand.
Q1 2020 Highlights:
Company commences COVID-19 test sales and reports $1.5 Million of revenue in Q1Gross margins of 71.5% on sales... More